Literature DB >> 19127062

Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts.

Takuhiro Uto1, Miguel A Contreras, Anne G Gilg, Inderjit Singh.   

Abstract

X-Adrenoleukodystrophy (X-ALD) is a peroxisomal disorder characterized by accumulation of very-long-chain (VLC) fatty acids, which induces inflammatory disease and alterations in cellular redox, both of which are reported to play a role in the pathogenesis of the severe form of the disease (childhood cerebral ALD). Here, we report on the status of oxidative stress (NADPH oxidase activity) and inflammatory mediators in an X-ALD lymphoblast cell line under nonstimulated conditions. X-ALD lymphoblasts contain nearly 7 times higher levels of the C(26:0) fatty acid compared to controls; these levels were downregulated by treatment with sodium phenylacetate (NaPA), lovastatin or the combination of both drugs. In addition, free-radicals synthesis was elevated in X-ALD lymphoblasts, and protein levels of the NADPH oxidase gp91(PHOX) membrane subunit were significantly upregulated, but no changes were observed in the p47(PHOX) and p67(PHOX) cytoplasmic subunits. Unexpectedly, there was no increase in gp91(PHOX) mRNA levels in X-ALD lymphoblasts. Furthermore, X-ALD lymphoblasts produced higher levels of nitric oxide (NO) and cytokines (tumor necrosis factor-alpha and interleukin 1 beta), and treatment with NaPA or lovastatin decreased the synthesis of NO. Our data indicate that X-ALD lymphoblasts are significantly affected by the accumulation of VLC fatty acids, which induces changes in the cell membrane properties/functions that may, in turn, play a role in the development/progression of the pathogenesis of X-ALD disease. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19127062      PMCID: PMC2744110          DOI: 10.1159/000191212

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  39 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Th 1 cytokine production by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy.

Authors:  N Merendino; C Avellino; M Cappa; S Salvati
Journal:  J Neurol Sci       Date:  2001-01-01       Impact factor: 3.181

3.  Inducible nitric oxide synthase in the central nervous system of patients with X-adrenoleukodystrophy.

Authors:  A G Gilg; A K Singh; I Singh
Journal:  J Neuropathol Exp Neurol       Date:  2000-12       Impact factor: 3.685

4.  The use of diphenylene iodonium, an inhibitor of NADPH oxidase, to investigate the antimicrobial action of human monocyte derived macrophages.

Authors:  A K Robertson; A R Cross; O T Jones; P W Andrew
Journal:  J Immunol Methods       Date:  1990-10-19       Impact factor: 2.303

5.  Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.

Authors:  R A Knazek; W B Rizzo; J D Schulman; J R Dave
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy.

Authors:  C R Vargas; M Wajner; L R Sirtori; L Goulart; M Chiochetta; D Coelho; A Latini; S Llesuy; A Bello-Klein; R Giugliani; M Deon; C F Mello
Journal:  Biochim Biophys Acta       Date:  2004-01-20

7.  Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies.

Authors:  Ajaib Singh Paintlia; Anne Genevieve Gilg; Mushfiquddin Khan; Avtar Kaur Singh; Ernest Barbosa; Inderjit Singh
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

8.  Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.

Authors:  O Lazo; M Contreras; M Hashmi; W Stanley; C Irazu; I Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.

Authors:  R W Whitcomb; W M Linehan; R A Knazek
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

10.  Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum.

Authors:  Y Fujiki; A L Hubbard; S Fowler; P B Lazarow
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

View more
  16 in total

1.  ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.

Authors:  Mauhamad Baarine; Craig Beeson; Avtar Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

2.  Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy.

Authors:  Mushfiquddin Khan; Jaspreet Singh; Anne G Gilg; Takuhiro Uto; Inderjit Singh
Journal:  J Lipid Res       Date:  2010-02-20       Impact factor: 5.922

3.  Lymphoblastoid cell lines for diagnosis of peroxisome biogenesis disorders.

Authors:  Sabine Grønborg; Ralph Krätzner; Hendrik Rosewich; Jutta Gärtner
Journal:  JIMD Rep       Date:  2011-06-22

Review 4.  Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

Authors:  Inderjit Singh; Aurora Pujol
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

Review 5.  Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy.

Authors:  Marion Deon; Desirèe P Marchetti; Bruna Donida; Moacir Wajner; Carmen Vargas
Journal:  Cell Mol Neurobiol       Date:  2015-07-14       Impact factor: 5.046

6.  HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.

Authors:  Jaspreet Singh; Mushfiquddin Khan; Inderjit Singh
Journal:  J Lipid Res       Date:  2011-09-04       Impact factor: 5.922

7.  Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model.

Authors:  Jie Gong; Yunyun Liu; Tsai-Hua Chung; Liu Xu; Troy C Lund; Lung-Ji Chang
Journal:  Gene Ther       Date:  2022-07-06       Impact factor: 5.250

8.  Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.

Authors:  Jaspreet Singh; Mushfiquddin Khan; Inderjit Singh
Journal:  Biochim Biophys Acta       Date:  2013-01-11

9.  X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.

Authors:  Franziska D Weber; Christoph Wiesinger; Sonja Forss-Petter; Günther Regelsberger; Angelika Einwich; Willi H A Weber; Wolfgang Köhler; Hannes Stockinger; Johannes Berger
Journal:  Hum Mol Genet       Date:  2013-12-20       Impact factor: 6.150

10.  Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E).

Authors:  Amira Zarrouk; Anne Vejux; Thomas Nury; Hammam I El Hajj; Madouda Haddad; Mustapha Cherkaoui-Malki; Jean-Marc Riedinger; Mohamed Hammami; Gérard Lizard
Journal:  Oxid Med Cell Longev       Date:  2012-08-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.